Interleukin-6, hepatocyte growth factor, and their receptors in biliary epithelial cells during a type I ductular reaction in mice: Interactions between the periductal inflammatory and stromal cells and the biliary epithelium

Hepatology

Volumn 28, Issue 5, 1998, Pages 1260-1268

  Liu, Zejin ^a   Sakamoto, Toshikl ^a   Ezure, Tsukasa ^a   Yokomuro, Shigeki ^a   Murase, Noriko ^a   Michalopoulos, George ^a   Demetris, Anthony J ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; SCATTER FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BILE DUCT LIGATION; DNA SYNTHESIS; HEPATOBILIARY SYSTEM; LIVER CELL; LIVER CIRRHOSIS; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ANIMALS; BILE DUCTS; CELL DIVISION; CHOLANGITIS; DNA; EPITHELIAL CELLS; GENE EXPRESSION; HEPATOCYTE GROWTH FACTOR; INTERLEUKIN-6; LIGATION; LIVER; MALE; MICE; MICE, INBRED C57BL; ORGAN SIZE; PROTO-ONCOGENE PROTEINS C-MET; RECEPTORS, INTERLEUKIN-6; RNA, MESSENGER; STROMAL CELLS;

EID: 0031788501     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510280514     Document Type: Article

References (20)

1. Popper H, Kent G, Stein R. Ductular cell reaction in the liver in hepatic injury. J Mt Sinai Hosp 1957;24:551-556.
2. Popper H. The relation of mesenchymal cell products to hepatic epithelial systems. [Review]. Prog Liver Dis 1990;9:27-38.
3. Burt AD, MacSween RN. Bile duct proliferation - its true significance? [Review]. Histopathology 1993;23:599-602.
4. Polimeno L, Azzarone A, Zeng QH, et al. Cell proliferation and oncogene expression after bile duct ligation in the rat: evidence of a specific growth effect on bile duct cells. HEPATOLOGY 1995;21:1070-1078.
5. Slott PA, Liu MH, Tavoloni N. Origin, pattern, and mechanism of bile duct proliferation following biliary obstruction in the rat [Comments]. Gastroenterology 1990;99:466-477.
6. Oguey D, Marti U, Reichen J. Epidermal growth factor receptor in chronic bile duct obstructed rats: implications for maintenance of hepatocellular mass. Eur J Cell Biol 192;59:187-195.
7. Aldana PR, Goerke ME, Carr SC, Tracy TF Jr. The expression of regenerative growth factors in chronic liver injury and repair. J Surg Res 1994;57:711-717.
8. Napoli J, Prentice D, Niinami C, Bishop GA, Desmond P, McCaughan GW. Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor β in a bile duct Iigated rat model of cirrhosis. HEPATOLOGY 1997;26:624-633.
9. Matsumoto K, Fujii H, Michalopoulos G, Fung JJ, Demetris AJ. Human biliary epithelial cells secrete and respond to cytokines and hepatocyte growth factors in vitro: interleukin-6, hepatocyte growth factor and epidermal growth factor promote DNA synthesis in vitro. HEPATOLOGY 1994;20:376-382.
10. Kountouras J, Billing BH, Scheuer PJ. Prolonged bile duct obstruction: a new experimental model for cirrhosis in the rat. Br J Exp Pathol 1984;65:305-311.
11. Medeiros MV, Freitas LA, Andrade ZA. Differences in hepatic pathology resulting from bile duct obstruction in young and old rats. Braz J Med Biol Res 1988;21:75-83.
12. 1 and mannose 6-phosphate/insulin-like growth factor-II receptor expression during intrahepatic bile duct hyperplasia and biliary fibrosis in the rat. Hepatology 1994;19:412-417.
13. Milani S, Herbst H, Schuppan D, Stein H, Surrenti C. Transforming growth factors beta 1 and beta 2 are differentially expressed in fibrotic liver disease. Am J Pathol 1991;139:1221-1229.
14. Okada K, Shimizu Y, Nambe S, Kiguchi K, Watanabe A. Interleukin-6 functions as an autocrine growth factor in a cholangiocarcinoma cell line. J Gastroenterol Hepatol 1994;9:462-467.
15. Rosen HR, Winkle PJ, Kendall BJ, Diehl DL. Biliary interleukin-6 and tumor necrosis factor-alpha in patients undergoing endoscopic retrograde cholangiopancreatography. Dig Dis Sci 1997;42:1290-1294.
16. Goydos JS, Brumfield AM, Frezza E, Booth A, Lotze MT, Carty SE. Marked elevation of serum interleukin-6 in patients with cholangiocarcinoma: validation of utility as a clinical marker. Ann Surg 1998;227:398-404.
17. Bemelmans MH, Gouma DJ, Greve JW, Buurman WA. Cytokines tumor necrosis factor and interleukin-6 in experimental biliary obstruction in mice. HEPATOLOGY 1992;15:1132-1136.
18. Patel T, LaRusso NF, Gores GJ. Interleukin-6 suppresses cholangiocyte apoptosis by down-regulation of Bax. HEPATOLOGY 1997;26:226A.
19. Liu Y, Michalopoulos GK, Zarnegar R. Structural and functional characterization of the mouse hepatocyte growth factor gene promoter. J Biol Chem 1994;269:4152-4160.
20. Moghul A, Lin L, Beedle A, et al. Modulation of c-MET proto-oncogene (HGF receptor) mRNA abundance by cytokines and hormones: evidence for rapid decay of the 8 kb c-MET transcript. Oncogene 1994;9:2045-2052.